美国密苏里州圣路易斯法院法官蒂莫西·博伊尔于周五批准了拜耳公司72.5亿美元的和解协议,旨在解决其除草剂“农达”(Roundup)被指控致癌引发的法律纠纷 1。这一裁决有望结束拜耳多年来在美国面临的昂贵诉讼,涉及约65,000起声称因使用该产品而患癌的索赔案件 12。尽管部分律师此前反对该方案并认为对个体的赔偿金额过低,但此次批准覆盖了目前及未来的绝大多数相关索赔 12。
拜耳首席执行官比尔·安德森称法院的最终批准是缓解公司诉讼风险的决定性里程碑 1。自2018年以630亿美元收购孟山都以来,拜耳股价已累计下跌46% 1。值得注意的是,该和解协议排除了仍在联邦法院审理的部分案件,据拜耳表示,约有200起此类案件仍在诉讼中 1。
此次判决发生在最高法院近期在John Durnell案中作出7比2裁决之后,该裁决认定联邦农药监管法禁止基于州法的警告缺失索赔,显著削弱了原告在州法下提起类似诉讼的能力 1。此前,拜耳曾在2020年为部分诉讼支付109亿美元和解金,但未能获得一项价值12.5亿美元的未来索赔和解案的法院批准 1。
Judge Timothy Boyer of the St. Louis court in Missouri approved a $7.25 billion settlement agreement on Friday between Bayer and plaintiffs alleging that the herbicide Roundup causes cancer 1. The ruling marks a decisive milestone for the company, which faces approximately 65,000 lawsuits claiming harm from the product 1. While the settlement aims to cover the vast majority of current and future claims, it has faced opposition from some attorneys who argue that individual compensation amounts are too low 12.
Bayer CEO Bill Anderson described the court’s final approval as a critical step in mitigating litigation risk 1. This development follows recent legal shifts that have weakened plaintiffs' ability to pursue state-law warning claims; specifically, the US Supreme Court ruled 7-2 in the John Durnell case that federal pesticide regulations preempt such state-based arguments 1. Despite this favorable regulatory context, Bayer’s stock price has fallen 46% since its 2018 acquisition of Monsanto for $63 billion 1.
The approved deal excludes certain cases still pending in federal courts, with Bayer indicating that roughly 200 of these lawsuits remain active 1. The company had previously paid $10.9 billion in settlements in 2020 for a subset of cases but failed to secure judicial approval for a separate $1.25 billion proposal covering future claims at that time 1. Tens of thousands of individuals are expected to receive payouts under the new comprehensive framework 2.
评论
还没有评论,欢迎留下第一条。